NEW YORK (Reuters Health) – For many patients with HIV receiving highly active antiretroviral therapy (HAART), routine bone mineral density (BMD) assessment may not be necessary because BMD…
NEW YORK (Reuters Health) – Besides preventing HIV-1 mother-to-child transmission (PMTCT), triple antiretroviral therapy during pregnancy improves pregnancy outcomes, according to findings published in the June 6th online…
NEW YORK (Reuters Health) – The dilemma of when to start antiretroviral therapy (ART) in patients presenting with tuberculous meningitis associated with HIV infection has been answered by…
NEW YORK (Reuters Health) – The combination of niacin and fenofibrate, along with diet and exercise, markedly improves the lipid profile of HIV patients on antiretroviral therapy (ART),…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses ICAMiA’s AIDS Training Program. For more information on ICAMiA’s important work in Africa, please read…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses the work that the Israel Consortium on AIDS Medicine in Africa (ICAMiA) collaborates on with…
NEW YORK (Reuters Health) – The risk of progression to AIDS in HIV-infected patients is significantly reduced when combined antiretroviral therapy is started at a CD4 count threshold…
NEW YORK (Reuters Health) – Outcomes among tuberculosis patients treated with a fixed-dose combination of four drugs are similar to those in patients treated with the same four…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses the importance of taking a holistic approach to AIDS work in Africa. For more information…
NEW YORK (Reuters Health) – The presence of low-frequency HIV-1 drug resistance mutations – especially against non-nucleoside reverse transcriptase inhibitors (NNRTIs) – confers a greater than twofold increased…